Dicerna Pharmaceuticals
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare diseases, viral infectious diseases, chronic liver diseases, and cardiometabolic diseases. Its principal development programs include nedosiran for the treatment of primary hyperoxaluria; RG6346 for the treatment of chronic hepatitis B virus infection; and a program for an undisclosed rare liver disease. The company's development programs also comprise DCR-A1AT programs; and a program for the treatment of neurodegeneration and pain. Dicerna Pharmaceuticals, Inc. has strategic collaborations with Novo Nordisk A/S, Roche, Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. The company was founded in 2006 and is headquartered in Lexington, Massachusetts.
Show More
CEO
Douglas Fambrough
Employees
302
Country
United States
ISIN
US2530311081
Listings
0 Comments
Share your thoughts
FAQs
What is Dicerna Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Dicerna Pharmaceuticals stocks are traded under the ticker DPL.STU.
How many employees does Dicerna Pharmaceuticals have?▼
As of November 1, 2026, the company has 302 employees.
In which sector is Dicerna Pharmaceuticals located?▼
Dicerna Pharmaceuticals operates in the Manufacturing sector.
When did Dicerna Pharmaceuticals complete a stock split?▼
Dicerna Pharmaceuticals has not had any recent stock splits.
Where is Dicerna Pharmaceuticals headquartered?▼
Dicerna Pharmaceuticals is headquartered in Lexington, United States.